ELIFE HLDGS (00223), which had been suspended from trading since December 2, 2024, for over a year, resumed trading this morning and saw its share price skyrocket by as much as 161% before paring gains. At the time of writing, the stock was up 70.64%, trading at HK$0.186, with a turnover of HK$2.9448 million. The company announced that it has met the conditions for resuming trading, which primarily included publishing all outstanding financial results and addressing any audit modifications; conducting an independent investigation into issues related to certain operating subsidiaries from the 2024 interim period, assessing the impact on the company's business operations and financial position, disclosing the investigation findings, and implementing appropriate remedial actions; demonstrating compliance with Listing Rule 13.24, meaning it has sufficient business operations or possesses tangible or intangible assets of substantial value; and keeping the market informed of all significant information. In an announcement on November 28, ELIFE HLDGS reported its results for the six months ended September 30, 2025, showing revenue from continuing operations of HK$60.928 million, a decrease of 49.0% year-on-year, and a profit attributable to company owners of HK$4.365 million, compared to a loss of HK$69.94 million in the same period last year. The announcement stated that this shift to profitability marks a significant turnaround, demonstrating the successful implementation of management's strategy to stabilize and restore the group's business operations.